1. Ocular pharmacokinetics of a topical ophthalmic nanomicellar solution of cyclosporine (Cequa®) for dry eye disease;Abhirup;Pharm. Res.,2019
2. Yan Aihui, Von Dem Bussche Annette, Kane Agnes B, & Robert H hurt, 2007. Tocopheryl polyethylene glycol succinate as a safe, antioxidant surfactant for processing carbon nanotubes and fullerenes. Carbon, 45(13), 2463-2470. DOI: 10.1016/j.carbon.2007.08.035.
3. Current perspectives on natamycin in ocular fungal infections;Akash;J. Drug Delivery Sci. Technol.,2017
4. Formulation development, optimization, and in vitro–in vivo characterization of natamycin-loaded pegylated nano-lipid carriers for ocular applications;Akash;J. Pharm. Sci.,2018
5. Alcon Laboratories Inc., 2008. Natacyn®(Natamycin) [Package insert], NDA 50-514/S-009, Alcon Laboratories Inc., Fort Worth, Texas 76134 USA, U.S. Food and Drug Administration. www.accessdata.fda.gov/drugsatfda_docs/label/2008/050514s009lbl.pdf.